Ernesto Korbenfeld

3PUBLICATIONS
35CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 29, 2024
Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis.

Agustín Ciapponi, Ariel Bardach, Carla Colaci

|Nov 14, 2023
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.

Joaquin Mateo, Johann S de Bono, Karim Fizazi

|Nov 01, 2022
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2, or ATM Alterations Identified by Testing Circulating Tumor DNA.

Nobuaki Matsubara, Johann de Bono, David Olmos

Pageof 1